Kidney TransplantationImmunosuppressive AgentsGraft RejectionTacrolimusCyclosporineMycophenolic AcidGraft SurvivalBK VirusKidneyPolyomavirus InfectionsKidney Failure, ChronicTransplantation, HomologousKidney DiseasesImmunosuppressionQ-SortPostoperative ComplicationsTissue DonorsTime FactorsAntilymphocyte SerumTransplantationHeart TransplantationLiver TransplantationTransplantsRetrospective StudiesTreatment OutcomeDrug MonitoringCalcineurinCreatinineFollow-Up StudiesLung TransplantationRisk FactorsLiving DonorsSirolimusGlomerular Filtration RateProspective StudiesBiopsyWaiting ListsDrug Therapy, CombinationTissue and Organ ProcurementSunlightCytomegalovirus InfectionsCadaverOrgan TransplantationIncidenceBiological MarkersPancreas TransplantationHistocompatibility TestingImmunocompromised HostBone Marrow TransplantationTransplantation ImmunologyDelayed Graft FunctionKidney Function TestsIsoantibodiesRenal DialysisCytomegalovirusCyclosporinsTablets, Enteric-CoatedDirected Tissue DonationKidney TubulesHLA AntigensHematopoietic Stem Cell TransplantationHeart-Lung TransplantationBronchiolitis ObliteransPostoperative PeriodAzathioprinePrimary Graft DysfunctionGingival OvergrowthLymphoproliferative DisordersGanciclovirRenal InsufficiencyLiver FailureAcute Kidney InjurySurvival RateIranCohort StudiesAntiviral AgentsSurvival AnalysisRecurrenceMonitoring, ImmunologicMycosesAcute DiseaseHistocompatibilityGingival HyperplasiaPrognosisTransplantation ToleranceRisk AssessmentProportional Hazards ModelsPrednisoneGraft vs Host DiseaseKaplan-Meier EstimateComplement C4bFetal Tissue TransplantationOpportunistic InfectionsPlasmapheresisKidney CortexMultivariate AnalysisChronic DiseaseProteinuriaChi-Square DistributionDonor Selection